Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 696,195 | reported | 29 Apr 2026 | tx 179+3,223,130−1,459,631 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Apr 2026 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 2.08 USD | 10b5-1 |
| 29 Apr 2026 | SALE | Kymera Therapeutics, Inc. | 17,005 | 80.74 USD | 10b5-1 |
| 29 Apr 2026 | SALE | Kymera Therapeutics, Inc. | 12,059 | 81.70 USD | 10b5-1 |
| 29 Apr 2026 | SALE | Kymera Therapeutics, Inc. | 936 | 82.45 USD | 10b5-1 |
| 29 Apr 2026 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 0.00 USD | 10b5-1deriv |
| 02 Mar 2026 | GRANT_AWARD | Kymera Therapeutics, Inc. | 215,000 | 0.00 USD | deriv |
| 25 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 8 | 93.49 USD | anomaly |
| 25 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 1,501 | 92.81 USD | |
| 25 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 3,293 | 91.76 USD | |
| 25 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 19,764 | 89.78 USD | |
| 25 Feb 2026 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 2.08 USD | |
| 25 Feb 2026 | SALE | Kymera Therapeutics, Inc. | 5,434 | 90.39 USD | |
| 25 Feb 2026 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,118 | 32.07 USD | |
| 05 Jan 2026 | EXERCISE | Kymera Therapeutics, Inc. | 3,118 | 0.00 USD | deriv |
| 31 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 2.08 USD | |
| 31 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 6,014 | 78.52 USD | |
| 31 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 23,986 | 77.95 USD | |
| 31 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 17 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 2,595 | 38.53 USD | |
| 17 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 2,595 | 0.00 USD | deriv |
| 08 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 100,000 | 2.08 USD | |
| 08 Dec 2025 | SALE | Kymera Therapeutics, Inc. | 100,000 | 89.17 USD | |
| 08 Dec 2025 | EXERCISE | Kymera Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 29 Oct 2025 | EXERCISE | Kymera Therapeutics, Inc. | 30,000 | 2.08 USD |